n summary, our compelling findings demonstrate that allicin may be a promising substitute that protects against APAP-induced acute liver damage, in which the underlying mechanism involved is through inactivating intracellular TLR4/NF-κB signalling pathway, thereby attenuating intrahepatic inflammatory stress.